N07.7 Hereditary nephropathy, not elsewhere classified with diffuse crescentic glomerulonephritis

Name of the Condition

• Hereditary Nephropathy, Not Elsewhere Classified with Diffuse Crescentic Glomerulonephritis
• ICD-10 Code: N07.7

Summary

Hereditary nephropathy, not elsewhere classified with diffuse crescentic glomerulonephritis, is a genetic kidney disorder characterized by widespread inflammation and crescent formation in the glomeruli, the kidney's filtering units. This condition involves diffuse (widespread) crescentic (crescent-shaped) lesions, leading to rapid impairment of kidney function. It is inherited and may present with severe symptoms, requiring prompt diagnosis and management to slow disease progression.

Causes

This condition is caused by genetic mutations that disrupt normal kidney structure and function, leading to diffuse crescentic glomerulonephritis. The specific genetic defects are not always identified, but the hereditary nature is a key diagnostic feature. Inheritance patterns may vary, and the condition is passed down through families.

Risk Factors

• Family history of kidney disease: A genetic predisposition increases the likelihood of developing the condition.
• Inherited genetic mutations: Specific gene variants associated with glomerular inflammation and crescent formation.
• Consanguinity: Higher risk in populations with a history of intermarriage, which can increase the chance of recessive genetic disorders.

Symptoms

• Rapid decline in kidney function, potentially leading to acute kidney injury.
• Hematuria (blood in urine), which may be microscopic or visible.
• Proteinuria (excess protein in urine), potentially causing foamy urine.
• Hypertension (high blood pressure) due to impaired kidney function.
• Edema (swelling) from fluid retention.

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging. Urinalysis may show hematuria and proteinuria. Blood tests assess kidney function (e.g., creatinine, BUN). A kidney biopsy is often performed to confirm diffuse crescentic glomerulonephritis and rule out other causes. Genetic testing may be considered to identify hereditary factors, though specific mutations are not always detectable.

Treatment Options

Treatment focuses on slowing disease progression and managing complications. Immunosuppressive therapies (e.g., corticosteroids, cytotoxic agents) may be used to reduce inflammation. Blood pressure control with ACE inhibitors or ARBs helps protect kidney function. Dialysis or kidney transplantation may be necessary in advanced cases. Supportive care includes managing fluid balance and electrolyte levels.

Prognosis and Follow-Up

Prognosis varies depending on the severity of kidney damage and response to treatment. Early intervention may slow progression, but diffuse crescentic glomerulonephritis often leads to significant renal impairment. Regular follow-up with nephrology is essential to monitor kidney function, adjust therapies, and address complications. Long-term outcomes may include chronic kidney disease or end-stage renal disease.

Complications

• Rapid progression to end-stage renal disease.
• Hypertension and cardiovascular complications.
• Electrolyte imbalances and fluid overload.
• Increased risk of infections due to immunosuppressive therapies.

Lifestyle & Prevention

• Maintain a low-sodium, kidney-friendly diet to support blood pressure control.
• Avoid nephrotoxic medications (e.g., certain NSAIDs) unless prescribed.
• Stay hydrated, but follow medical advice for fluid intake if kidney function is impaired.
• Regular exercise and weight management may help manage hypertension.
• Genetic counseling is recommended for families with a history of hereditary nephropathy.

When to Seek Professional Help

Seek immediate medical attention if you experience:

• Sudden decrease in urine output.
• Severe swelling (edema) in the legs, ankles, or face.
• Persistent high blood pressure.
• Blood in urine or foamy urine.
• Unexplained fatigue or shortness of breath, which may indicate kidney failure.

Tips for Medical Coders

When coding N07.7, ensure documentation supports the presence of diffuse crescentic glomerulonephritis in the context of hereditary nephropathy. Verify that the condition is not classified elsewhere (e.g., specific genetic syndromes with defined codes). Document the hereditary nature and glomerular findings clearly to justify the code. Review clinical notes for biopsy results, genetic testing, or family history to confirm the diagnosis.